Scientists have developed a slurry-based process that can revolutionize carbon capture. The slurry, consisting of a porous powder suspended in glycol, offers the efficient large-scale implementation of a liquid while maintaining the lower costs and energy efficiency of solid carbon-capturing materials.
The Graphene Special Interest Group has published a Graphene Think Piece. The document was initiated by the Technology Strategy Board to 'inform a view on where and how the UK might best gain economic value from graphene related activities'.
The 7th annual meeting of the World Molecular Imaging Society, which just concluded in Seoul, Korea, highlighted new discoveries in molecular imaging during 180 oral presentations and more than 650 scientific poster presentations from world-renowned institutions from around the globe.
New research by materials scientists has yielded greater understanding of what particular nanocrystals look like individually and how they fit together as they form larger structures called supercrystals. Such knowledge could lead to effective bottom-up engineering of new materials for applications ranging from solar cells to electronic components.
For a long time optical microscopy was held back by a presumed limitation: that it would never obtain a better resolution than half the wavelength of light. Helped by fluorescent molecules the Nobel Laureates in Chemistry 2014 ingeniously circumvented this limitation. Their ground-breaking work has brought optical microscopy into the nanodimension.
A proposal to develop a new way to remotely control brain cells is among the first to receive funding from the BRAIN initiative. The project will make use of a technique called radiogenetics that combines the use of radio waves or magnetic fields with nanoparticles to turn neurons on or off.
A $1 million grant from the National Cancer Institute's Small Business Innovation Research program will enable UCLA scientists and industry partners to take an innovative lung cancer treatment through the final steps toward its first clinical trial.